BiotechTube
Home/Calosyn Pharma/David Waddell, M.D., FAAOS, FAOA
DW

David Waddell, M.D., FAAOS, FAOA

Co-Founder & Chief Medical Officer

Calosyn Pharma

Therapeutic Areas

OsteoarthritisPain

Calosyn Pharma Pipeline

DrugIndicationPhase
CAL-05CRModerate to Severe Osteoarthritis PainPre-clinical

Leadership Team at Calosyn Pharma

RG
Reid Grimes, Jr., Ph.D., M.B.A.
President & CEO
View full Calosyn Pharma profile